Skip to content

Clinical trials

Glioblastoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Country / region: South Korea Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20093
20122
20153
20163
20171
20183
20192
20207
20213
20223
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting6
Unknown status5
Terminated4
Active, not recruiting3
No longer available1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
CHA University2
Genexine, Inc.2
InSightec2
Novartis Pharmaceuticals2
Asan Medical Center1
Bayer1
BeyondBio Inc.1
Chungnam National University Hospital1
Clinical Research Center for Solid Tumor, Korea1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma37
Astrocytoma6
Brain Neoplasms6
Glioma6
Cholangiocarcinoma3
Melanoma3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Central Nervous System Neoplasms2
Colorectal Neoplasms2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.